Long-Term Liabilities: The sum of all non-current liabilities.
iTeos Therapeutics, Inc. (ITOS) had Long-Term Liabilities of $53.01M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-38.22M |
|
-- |
|
-- |
|
$47.23M |
|
$-47.23M |
|
$11.23M |
|
$-36.00M |
|
$-36.00M |
|
$-38.22M |
|
$-38.22M |
|
$-38.22M |
|
$-38.22M |
|
$-47.23M |
|
$-46.93M |
|
35.84M |
|
35.84M |
|
$-1.07 |
|
$-1.07 |
|
| Balance Sheet Financials | |
$480.39M |
|
$5.26M |
|
$149.38M |
|
$629.77M |
|
$35.56M |
|
-- |
|
|
Long-Term Liabilities |
$53.01M |
$88.57M |
|
$541.20M |
|
$541.20M |
|
$541.20M |
|
35.84M |
|
| Cash Flow Statement Financials | |
$-32.40M |
|
$-69.60M |
|
$0.02M |
|
$251.45M |
|
$146.92M |
|
$-104.53M |
|
$7.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.06% |
|
-7.06% |
|
-6.07% |
|
-7.06% |
|
$15.10 |
|
$-0.93 |
|
$-0.90 |
|